Citation Impact
Citing Papers
The clinical symptoms of Parkinson's disease
2016 Standout
Manganese transporter Slc39a14 deficiency revealed its key role in maintaining manganese homeostasis in mice
2017
Genomic landscape of the individual host response and outcomes in sepsis: a prospective cohort study
2016
Diagnostic performance of clinical motor and non‐motor tests of Parkinson disease: a matched case–control study
2008
[123I] FP‐CIT spect study in vascular parkinsonism and Parkinson's disease
2007
Normal frontal perfusion in patients with frozen gait
1998
Parkinson disease
2017 Standout
Prognostic factors for the progression of Parkinson's disease: A systematic review
2007
A longitudinal study of neuropsychological change in individuals with Parkinson's disease
2003
Parkinson's disease
2021 Standout
Gastrointestinal dysfunction in Parkinson's disease
2003 Standout
Influence of dopaminergic medication on automatic postural responses and balance impairment in Parkinson's disease
1996
Montreal Cognitive Assessment Performance in Patients with Parkinson's Disease with “Normal” Global Cognition According to Mini‐Mental State Examination Score
2008
Systematic Review of the Prevalence and Incidence of Parkinson’s Disease in Asia
2009
Non-motor symptoms of Parkinson's disease: dopaminergic pathophysiology and treatment
2009 Standout
Geographic and Ethnic Variation in Parkinson Disease: A Population-Based Study of US Medicare Beneficiaries
2010
Ropinirole versus bromocriptine in the treatment of early Parkinson's disease: A 6‐month interim report of a 3‐year study
1998
Utility of the WHO‐five well‐being index as a screening tool for depression in Parkinson's disease
2010
Medical decision‐making capacity in cognitively impaired Parkinson's disease patients without dementia
2008
The Incidence of Parkinson's Disease: A Systematic Review and Meta-Analysis
2016
Does the ADL part of the unified Parkinson's disease rating scale measure ADL? An evaluation in patients after pallidotomy and thalamic deep brain stimulation
2002
Predictors of deterioration in health‐related quality of life in Parkinson's disease: Results from the DATATOP trial
2007
Unclassifiable parkinsonism in two European tertiary referral centres for movement disorders
2003
Parkinson's disease: clinical features and diagnosis
2008 Standout
Dual‐tasking effects on gait variability: The role of aging, falls, and executive function
2006
Stages in the development of Parkinson’s disease-related pathology
2004 Standout
Continuous subcutaneous apomorphine therapy improves dyskinesias in Parkinson's disease: A prospective study using single‐dose challenges
2004
Subthalamic nucleus deep brain stimulation: Summary and meta-analysis of outcomes
2006 Standout
Dopaminergic modulation of cortical function in patients with Parkinson's disease
2002
Factor structure of the unified Parkinson's disease rating scale: Motor examination section
1998
Oro‐buccal symptoms (dysphagia, dysarthria, and sialorrhea) in patients with Parkinson’s disease: preliminary analysis from the French COPARK cohort
2011
Overdependence on degraded gist memory in Alzheimer's disease.
2006 Standout
Effects of rivastigmine in patients with and without visual hallucinations in dementia associated with Parkinson's disease
2006
Core assessment program for intracerebral transplantations (CAPIT)
1992 Standout
Incidence of Parkinson's disease and parkinsonism in northern Sweden: A population‐based study
2010
The Sydney multicenter study of Parkinson's disease: The inevitability of dementia at 20 years
2008 Standout
The Parkinson's Disease Questionnaire (PDQ-39): development and validation of a Parkinson's disease summary index score
1997 Standout
Parkinson's disease
2009 Standout
Transplantation of Embryonic Dopamine Neurons for Severe Parkinson's Disease
2001 Standout
Transient mania with hypersexuality after surgery for high frequency stimulation of the subthalamic nucleus in Parkinson's disease
2002
The role of executive function and attention in gait
2007 Standout
Air pollution: mechanisms of neuroinflammation and CNS disease
2009 Standout
Constipation in parkinson's disease: Objective assessment and response to psyllium
1997
Epidemiology and etiology of Parkinson’s disease: a review of the evidence
2011
Neurotoxicity following chronic intravenous use of “Russian Cocktail”
2009
Glutamatergic mechanisms in the dyskinesias induced by pharmacological dopamine replacement and deep brain stimulation for the treatment of Parkinson's disease
2011
Epidemiology of Parkinson’s disease
2017 Standout
Incidence of Parkinson's Disease: Variation by Age, Gender, and Race/Ethnicity
2003 Standout
Falls and freezing of gait in Parkinson's disease: A review of two interconnected, episodic phenomena
2004 Standout
Prevalence of Parkinson's disease in the L'Aquila district, central Italy
2005
The early-onset torsion dystonia gene (DYT1) encodes an ATP-binding protein
1997 Standout
Characterisation of tremor‐associated local field potentials in the subthalamic nucleus in Parkinson’s disease
2009
A Five-Year Study of the Incidence of Dyskinesia in Patients with Early Parkinson's Disease Who Were Treated with Ropinirole or Levodopa
2000 Standout
Parkinson's disease
2015 Standout
A double‐blind controlled trial of bilateral fetal nigral transplantation in Parkinson's disease
2003
The need for levodopa as an end point of Parkinson's disease progression in a clinical trial of selegiline and α‐tocopherol
1997
Five-Year Follow-up of Bilateral Stimulation of the Subthalamic Nucleus in Advanced Parkinson's Disease
2003 Standout
Gastrointestinal symptoms in Parkinson's disease
1991
How well do caregivers detect mild cognitive change in Parkinson's disease?
2010
Slower progression of Parkinson's disease with ropinirole versus levodopa: The REAL‐PET study
2003
A longitudinal study of neuropsychological change in individuals with Parkinson's disease
2003
Parkinsonism and Parkinson's disease in the elderly: A community‐based survey in Brazil (the Bambuí study)
2006
Diagnostic criteria for mild cognitive impairment in Parkinson's disease: Movement Disorder Society Task Force guidelines
2012 Standout
Characterization of freezing of gait subtypes and the response of each to levodopa in Parkinson's disease
2003
The epidemiology of Parkinson's disease: risk factors and prevention
2016 Standout
Genetic mapping of “Lubag” (X‐linked dystonia‐parkinsonism) in a filipino kindred to the pericentromeric region of the X chromosome
1991
Rating impairment and disability in Parkinson's disease: Evaluation of the unified Parkinson's disease rating scale
1994
Smell identification ability in twin pairs discordant for Parkinson's disease
2005
Gastrointestinal symptoms in parkinson disease: 18‐month follow‐up study
1993
Consensus statement on the role of acute dopaminergic challenge in Parkinson's disease
2001
Movement Disorder Society Task Force report on the Hoehn and Yahr staging scale: Status and recommendations The Movement Disorder Society Task Force on rating scales for Parkinson's disease
2004 Standout
Non-motor features of Parkinson disease
2017 Standout
The size and burden of mental disorders and other disorders of the brain in Europe 2010
2011 Standout
Visual symptoms in Parkinson's disease and Parkinson's disease dementia
2011
The Neuroendocrinology of Stress: A Never Ending Story
2008 Standout
Coherence analysis of local field potentials in the subthalamic nucleus: differences in parkinsonian rest and postural tremor
2010
A review of recent strategies for acid mine drainage prevention and mine tailings recycling
2018 Standout
Mechanisms of lead and manganese neurotoxicity
2013
Psychosis, apathy, depression and anxiety in Parkinson's disease
2012
Parkinson's disease motor subtypes and mood
2011
Dual tasking, gait rhythmicity, and Parkinson's disease: Which aspects of gait are attention demanding?
2005
Defecatory function in Parkinson's disease: Response to apomorphine
1993
The immunopathology of sepsis and potential therapeutic targets
2017 Standout
The growing use of herbal medicines: issues relating to adverse reactions and challenges in monitoring safety
2014 Standout
Parkinson Disease and Exercise
2013
Is quality of life in non‐demented Parkinson’s disease patients related to cognitive performance? A clinic‐based cross‐sectional study
2008
Effects of stereotactic neurosurgery on postural instability and gait in Parkinson's disease
2004
Estrogen promotes differentiation and survival of dopaminergic neurons derived from human neural stem cells
2004 StandoutNobel
Which clinical sign of Parkinson's disease best reflects the nigrostriatal lesion?
1997
Nonmotor versus motor symptoms: How much do they matter to health status in Parkinson's disease?
2011
Artificial intelligence in healthcare
2018 Standout
Long‐term benefits of rivastigmine in dementia associated with Parkinson's disease: An active treatment extension study
2005
Prevalence and incidence of Parkinson's disease in Europe
2005
Manganism in the 21st century: The Hanninen lecture
2013
Unified Parkinson's disease rating scale characteristics and structure
1994
NMDA receptor subunit diversity: impact on receptor properties, synaptic plasticity and disease
2013 Standout
Parkinson's Disease
2003 Standout
The WHO-5 Well-Being Index: A Systematic Review of the Literature
2015 Standout
Reliability of the columbia scale for assessing signs of parkinson's disease
1993
Chronic pain in Parkinson's disease: The cross‐sectional French DoPaMiP survey
2008
Manganese and Parkinson’s Disease: A Critical Review and New Findings
2010
Manganese Neurotoxicity: Lessons Learned from Longitudinal Studies in Nonhuman Primates
2008
Manganese Toxicity Upon Overexposure: a Decade in Review
2015
Mediterranean diet adherence is related to reduced probability of prodromal Parkinson's disease
2018
Interdisciplinary Home Visits for Individuals with Advanced Parkinson's Disease and Related Disorders
2018
Validity of the MoCA and MMSE in the detection of MCI and dementia in Parkinson disease
2009 Standout
Antioxidant supplements for prevention of mortality in healthy participants and patients with various diseases
2012 Standout
Robust classification of bacterial and viral infections via integrated host gene expression diagnostics
2016
Gut microbiota are related to Parkinson's disease and clinical phenotype
2014 Standout
Heavy Metals and Human Health: Mechanistic Insight into Toxicity and Counter Defense System of Antioxidants
2015 Standout
Neuropathology of prodromal Lewy body disease
2014
Exercise as medicine – evidence for prescribing exercise as therapy in 26 different chronic diseases
2015 Standout
Positron emission tomographic analysis of the nigrostriatal dopaminergic system in familial Parkinsonism associated with mutations in the Parkin gene
2001
Ferroptosis as a target for protection against cardiomyopathy
2019 Standout
Frequency Dependence of Signal Power and Spatial Reach of the Local Field Potential
2013 Standout
The MoCA
2010 Standout
Investigating the functional link between TMEM165 and SPCA1
2019 StandoutNobel
Evaluation of a modified inverted walking stick as a treatment for Parkinsonian freezing episodes
1990
The prevalence of Parkinson's disease: A systematic review and meta‐analysis
2014 Standout
Neuropathology of older persons without cognitive impairment from two community-based studies
2006 Standout
Projected number of people with Parkinson disease in the most populous nations, 2005 through 2030
2006 Standout
Rotenone, Paraquat, and Parkinson’s Disease
2011 Standout
Works of Pille Taba being referenced
Clinical, neuroimaging and neurophysiological features in addicts with manganese-ephedrone exposure
2009
Prevalence of Parkinson's disease in Estonia
2002
Metals and movement disorders
2013
Peripheral blood RNA gene expression profiling in patients with bacterial meningitis
2013
Lower limb performance in older female patients with Parkinson’s disease
2002
Irreversible motor impairment in young addicts ? ephedrone, manganism or both?
2007
Patient education in Parkinson's disease: Formative evaluation of a standardized programme in seven European countries
2006
Incidence of Parkinson’s Disease in Estonia
2003
Leg-Extension Strength and Chair-Rise Performance in Elderly Women with Parkinson’s Disease
2004
Manganese-Induced Parkinsonism due to Ephedrone Abuse
2011
Epidemiology of Parkinson's disease
2004